1-20 of 20
dipeptidyl-peptidase iv inhibitors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk

Available to Purchase
Rozalina G. McCoy, Kavya Sindhu Swarna, Joshua J. Neumiller, Eric C. Polley, Yihong Deng, Mindy M. Mickelson, Jeph Herrin
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):59–70
https://doi.org/10.2337/cd24-0007
Published: 13 September 2024
View articletitled, Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk
Open the PDF for Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk in another window
Journal Articles

A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications

Available to Purchase
Scott J. Pilla, Isabelle J. Wang, Olive Tang, Nancy L. Schoenborn, Cynthia M. Boyd, Michael P. Bancks, Nestoras N. Mathioudakis, Nisa M. Maruthur
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):33–42
https://doi.org/10.2337/cd24-0043
Published: 05 September 2024
View articletitled, A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications
Open the PDF for A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications in another window
Journal Articles

Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia

Free
David T. Broome, Alimitha Kodali, Danielle Phillips, Vinni Makin, Daniel Mendlovic, Robert S. Zimmerman
Journal: Clinical Diabetes
Clin Diabetes 2022;40(1):116–119
https://doi.org/10.2337/cd21-0042
Published: 01 January 2022
View articletitled, Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia
Open the PDF for Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia in another window
Journal Articles

Linagliptin-Induced Arthralgia

Free
Stefanie C. Nigro, Jennifer D. Goldman
Journal: Clinical Diabetes
Clin Diabetes 2022;40(1):109–112
https://doi.org/10.2337/cd20-0110
Published: 01 January 2022
View articletitled, Linagliptin-Induced Arthralgia
Open the PDF for Linagliptin-Induced Arthralgia in another window
Journal Articles

Sitagliptin-Induced Arthralgias: A Case Report

Free
Raven Jackson, Isabel Sbeiti, Gabrielle Vincent
Journal: Clinical Diabetes
Clin Diabetes 2020;38(3):315–317
https://doi.org/10.2337/cd19-0023
Published: 01 July 2020
View articletitled, Sitagliptin-Induced Arthralgias: A Case Report
Open the PDF for Sitagliptin-Induced Arthralgias: A Case Report in another window
Journal Articles

Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease

Open Access
Kenneth S. Hershon, Barbara R. Hirsch, Ola Odugbesan
Journal: Clinical Diabetes
Clin Diabetes 2019;37(3):250–259
https://doi.org/10.2337/cd18-0040
Published: 01 July 2019
View articletitled, Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
Open the PDF for Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease in another window
Journal Articles

Nonglycemic Outcomes of Antidiabetic Medications

Open Access
Christopher Morse, David Sze, Dhiren Patel, Jennifer Goldman
Journal: Clinical Diabetes
Clin Diabetes 2019;37(2):131–141
https://doi.org/10.2337/cd18-0015
Published: 01 April 2019
View articletitled, Nonglycemic Outcomes of Antidiabetic Medications
Open the PDF for Nonglycemic Outcomes of Antidiabetic Medications in another window
Journal Articles

Ensuring Our Future

Open Access
Stephen A. Brunton
Journal: Clinical Diabetes
Clin Diabetes 2018;36(3):216
https://doi.org/10.2337/cd18-0035
Published: 01 July 2018
View articletitled, Ensuring Our Future
Open the PDF for Ensuring Our Future in another window
Journal Articles

Timely News and Notes for Primary Care Providers From The American Diabetes Association

Open Access
Max Bingham, PhD
Journal: Clinical Diabetes
Clin Diabetes 2018;36(2):92–96
https://doi.org/10.2337/cd18-0007
Published: 01 April 2018
View articletitled, Timely News and Notes for Primary Care Providers From The American Diabetes Association
Open the PDF for Timely News and Notes for Primary Care Providers From The American Diabetes Association in another window
Journal Articles

Personalizing Type 2 Diabetes Management: Use of a Patient-Centered Approach to Individualizing A1C Goals and Pharmacological Regimens

Open Access
Sharon W. Lahiri
Journal: Clinical Diabetes
Clin Diabetes 2017;35(5):321–328
https://doi.org/10.2337/cd17-0083
Published: 01 December 2017
View articletitled, Personalizing Type 2 Diabetes Management: Use of a Patient-Centered Approach to Individualizing A1C Goals and Pharmacological Regimens
Open the PDF for Personalizing Type 2 Diabetes Management: Use of a Patient-Centered Approach to Individualizing A1C Goals and Pharmacological Regimens in another window
Journal Articles

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes

Open Access
Richard E. Pratley, Eugenio Cersosimo
Journal: Clinical Diabetes
Clin Diabetes 2017;35(3):141–153
https://doi.org/10.2337/cd16-0063
Published: 01 July 2017
View articletitled, Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes
Open the PDF for Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes in another window
Journal Articles

Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin

Open Access
Debbie A. Hinnen
Journal: Clinical Diabetes
Clin Diabetes 2015;33(4):175–180
https://doi.org/10.2337/diaclin.33.4.175
Published: 01 October 2015
View articletitled, Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin
Open the PDF for Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin in another window
Journal Articles

Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes

Free
Vani P. Sanon, MD, Saurabh Sanon, MD, Son V. Pham, MD, FACC, Robert Chilton, DO, FACC
Journal: Clinical Diabetes
Clin Diabetes 2014;32(3):121–126
https://doi.org/10.2337/diaclin.32.3.121
Published: 01 July 2014
View articletitled, Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes
Open the PDF for Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes in another window
Journal Articles

Trading Glucose Control for Hypertension: Lessons from Mother Nature

Free
Robert Chilton, DO, FACC, FAHA
Journal: Clinical Diabetes
Clin Diabetes 2013;31(1):21–24
https://doi.org/10.2337/diaclin.31.1.21
Published: 01 January 2013
View articletitled, Trading Glucose Control for Hypertension: Lessons from Mother Nature
Open the PDF for Trading Glucose Control for Hypertension: Lessons from Mother Nature in another window
Journal Articles

Management of Type 2 Diabetes: What Is the Next Step After Metformin?

Free
Sharon W. Lahiri, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):72–75
https://doi.org/10.2337/diaclin.30.2.72
Published: 01 April 2012
View articletitled, Management of Type 2 Diabetes: What Is the Next Step After Metformin?
Open the PDF for Management of Type 2 Diabetes: What Is the Next Step After Metformin? in another window
Journal Articles

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Free
Lisa S. Rotenstein, BA, Benjamin M. Kozak, BA, Joseph P. Shivers, BA, Mark Yarchoan, BA, John Close, MBA, Kelly L. Close, MBA
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):44–53
https://doi.org/10.2337/diaclin.30.2.44
Published: 01 April 2012
View articletitled, The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?
Open the PDF for The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? in another window
Journal Articles

Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence

Free
Timothy Reid, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(1):3–12
https://doi.org/10.2337/diaclin.30.1.3
Published: 01 January 2012
View articletitled, Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
Open the PDF for Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence in another window
Journal Articles

Diabetes Treatment: Oral Agents

Free
Michael J. Fowler, MD
Journal: Clinical Diabetes
Clin Diabetes 2010;28(3):132–136
https://doi.org/10.2337/diaclin.28.3.132
Published: 01 January 2010
View articletitled, Diabetes Treatment: Oral Agents
Open the PDF for Diabetes Treatment: Oral Agents in another window
Journal Articles

Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use

Free
John R. White, Jr., PA, PharmD
Journal: Clinical Diabetes
Clin Diabetes 2008;26(2):53–57
https://doi.org/10.2337/diaclin.26.2.53
Published: 01 April 2008
View articletitled, Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use
Open the PDF for Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use in another window
Journal Articles

Diabetes Treatment, Part 2: Oral Agents for Glycemic Management

Free
Michael J. Fowler, MD
Journal: Clinical Diabetes
Clin Diabetes 2007;25(4):131–134
https://doi.org/10.2337/diaclin.25.4.131
Published: 01 October 2007
View articletitled, Diabetes Treatment, Part 2: Oral Agents for Glycemic Management
Open the PDF for Diabetes Treatment, Part 2: Oral Agents for Glycemic Management in another window